中药提取物改善多囊卵巢综合征中胰岛素抵抗的研究进展  被引量:11

Research Progress in Improvement of Polycystic Ovary Syndrome with Insulin Resistance by Traditional Chinese Herb Extracts

在线阅读下载全文

作  者:周笑梦 李雪莲[1] ZHOU Xiao-meng;LI Xue-lian(Obstetrics and Gynecology Hospital of Fudan University,Shanghai 200090,China)

机构地区:[1]复旦大学附属妇产科医院,上海200090

出  处:《国际妇产科学杂志》2018年第3期287-290,305,共5页Journal of International Obstetrics and Gynecology

摘  要:多囊卵巢综合征(polycystic ovarian syndrome,PCOS)是一组以无排卵或稀发排卵、不孕、高雄激素血症等为主要表现的异质性内分泌疾病。胰岛素抵抗(insulin resistance,IR)不仅是PCOS的重要内分泌表现,同时也是其可能发病机制之一。近年来黄连素(berberine,BBR)、葛根素(puerarin)、隐丹参酮(cryptotanshintone)、甘草次酸(glycyrrhetinic acid)等中药提取物在PCOS患者中IR的疗效受到了广泛关注。大量研究表明中药提取物可通过腺苷酸活化蛋白激酶(adenosine 5′-monophosphate-activated protein kinase,AMPK)、丝裂原活化蛋白激酶(mitogen-activated protein kinase,MAPK)等多种途径有效改善PCOS患者IR情况。综述中药提取物在PCOS治疗中改善IR的可能机制。Polycystic ovarian syndrome(PCOS) is a group of heterogeneous endocrine diseases which is characterized by oligoovulatory and anovulatory, infertility, hyperandrogenism and so on. Insulin resistance(IR) is an important endocrine manifestation of PCOS, besides it is also one of the possible pathogenesis of PCOS. Recently berberine(BBR), puerarin,cryptotanshintone, glycyrrhetinic acid and other traditional Chinese herb extracts have attracted widespread attention in the treatment of IR in PCOS patients. A large number of studies show that the mechanism includes adenosine 5 ′-monophosphateactivated protein kinase(AMPK), mitogen-activated protein kinase(MAPK) and so on. This article is a review of the possibly mechanism about traditional Chinese herb extracts in the improvement of PCOS with insulin resistance.

关 键 词:多囊卵巢综合征 胰岛素抗药性 中药化学成份 中药提取物 

分 类 号:R285[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象